Louisiana's exclusive licensee of SYNC-PREVENT™ — the clinical status monitoring platform built on biomarker data, FDA-cleared devices, and longitudinal patient records. Eight specialized programs designed to surface the signal before it becomes a hospitalization.
BridgeCare Louisiana, LLC holds the exclusive license to deploy and operate SYNC-PREVENT™ across the state. Developed by Synchronize Health, LLC, SYNC-PREVENT™ is a clinical status monitoring platform integrating biomarker data, FDA-cleared device readings, and longitudinal patient records into a continuously updated picture of each patient's physiologic status.
Every program follows one principle: identify risk before symptoms appear, monitor continuously, and surface actionable intelligence to the ordering physician. The physician retains full clinical authority over every treatment decision. BridgeCare LA surfaces the data — it never makes the call.
Matthew E. Mazur, Jr. spent 25 years as an attorney in Florida, representing physicians across malpractice defense, general counsel, board proceedings, and regulatory matters. That work gave him an uncommon vantage point — not inside the exam room, but close enough to see what kept going wrong between visits.
The pattern was consistent: a patient leaves an appointment clinically stable, deteriorates over the following weeks with no one monitoring, and arrives at the emergency department in crisis. The data needed to intervene earlier — a trending weight change, a shifting lab value, a lapsed medication — often existed somewhere in the system. It simply never reached the physician in time to act.
Rather than design a solution in isolation, Matthew sought out leading clinical researchers who had spent their careers quantifying exactly this kind of preventable deterioration. He assembled a clinical advisory panel — including world-recognized experts in diabetes outcomes, health economics, and biomarker-driven risk modeling — and worked alongside them to architect SYNC-PREVENT™: a platform grounded in published evidence, built around FDA-cleared devices, and structured so that the physician retains full clinical authority at every step.
He founded Synchronize Health, LLC to develop and license the platform, and launched BridgeCare Louisiana, LLC as its exclusive operator in the state — bridging the gap between the risk the data reveals and the clinical response the patient needs.
Fluid has been quietly collecting for three weeks. Nothing hurts enough to pick up the phone. When it finally does, the week turns into a Friday-night ambulance ride and five days on a ward — the kind that lands on a quality report and stays on a family's calendar for months.
Run the same three weeks again and they go differently. The signal reaches the physician while it's still only a signal — early enough for a dose change and a phone call instead of an admission. The patient never learns how close that Friday night came.
None of this is hypothetical. It's the exact pattern the evidence behind the platform was built to interrupt.
The physician gets to act sooner and with more context, well before the situation announces itself in the ER.
The patient keeps the week — at home and living it, not admitted to a bed.
The avoidable cost never lands: no claim, no readmission, no missed quality measure.
The whole difference comes down to one thing: whether the person dialing already knows what this patient's own data has been signaling all along.
President
As president, Matthew oversees the development and deployment of SYNC-PREVENT™ across Louisiana — translating clinical research into operational monitoring programs that give physicians the structured picture they need to intervene weeks before a crisis, not after one.
BBA, University of Miami (1994). JD, University of Miami School of Law (1998), cum laude. Member of the Florida Bar. Admitted to the U.S. District Courts for the Southern and Northern Districts of Florida.
Clinical Advisory Panel
Our advisory panel brings decades of leadership in diabetes research, health economics, and clinical innovation to shape how BridgeCare LA delivers monitoring that matters.
Professor of Medicine & Chief, Section of Endocrinology · Tulane University Medical Center
Past President for Science and Medicine of the American Diabetes Association. Professor of Medicine, Assistant Dean for Clinical Research, and holder of the Tullis-Tulane Alumni Chair in Diabetes at Tulane University.
Co-PI of REACHNET and site PI for the All of Us Program. Editor-in-Chief of Diabetes Care (2007–2011), with over 500 publications and an H-index of 109.
Neal A. & Mary Vanselow Endowed Chair, Health Policy & Management · Tulane University
Founding Director of Tulane’s Health Systems Analytics Research Center (HSARC). Clinical Faculty in Endocrinology and Psychiatry at Tulane’s Department of Medicine.
PI and Co-PI for over 40 research grants from AHRQ, CDC, NIH, and PCORI. Over 300 peer-reviewed publications. Associate Editor of Value In Health and Co-Editor-in-Chief of Pharmacoeconomics and Policy.
Talk to us about deploying clinical monitoring programs for your practice or health system across Louisiana.
Book a Consultation